ResearcherUniversity of HelsinkiActive in the last 2 years
Mirjami Kaasinen
Matched on OpenAlex author ID A5052367962. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper
Papers 2
- The prognostic significance of MMP-8 tissue Immunoexpression in pancreatic ductal adenocarcinoma after neoadjuvant therapy. Co-author DOI 10.1038/s41598-025-10538-5↗
- Matrix Metalloproteinase 8 Expression in a Tumour Predicts a Favourable Prognosis in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/ijms23063314↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hanna E. Seppänen · 2 shared papers, 2022–2025 · strength 0.42
- Paper The prognostic significance of MMP-8 tissue Immunoexpression in pancreatic ductal adenocarcinoma after neoadjuvant ther… DOI 10.1038/s41598-025-10538-5↗
- Paper Matrix Metalloproteinase 8 Expression in a Tumour Predicts a Favourable Prognosis in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/ijms23063314↗
- Caj H. Haglund · 2 shared papers, 2022–2025 · strength 0.42
- Paper The prognostic significance of MMP-8 tissue Immunoexpression in pancreatic ductal adenocarcinoma after neoadjuvant ther… DOI 10.1038/s41598-025-10538-5↗
- Paper Matrix Metalloproteinase 8 Expression in a Tumour Predicts a Favourable Prognosis in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/ijms23063314↗
- Malin Sund · 2 shared papers, 2022–2025 · strength 0.42
- Paper The prognostic significance of MMP-8 tissue Immunoexpression in pancreatic ductal adenocarcinoma after neoadjuvant ther… DOI 10.1038/s41598-025-10538-5↗
- Paper Matrix Metalloproteinase 8 Expression in a Tumour Predicts a Favourable Prognosis in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/ijms23063314↗
- Annika Eurola · 1 shared paper, 2025 · strength 0.25
- Ella Kesti · 1 shared paper, 2025 · strength 0.25
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.